Clinical trial
An Observational Study of the Treatment of Multiple Myeloma in Routine Clinical Practice
NCT01241396 is registered in ClinicalTrials.gov with Janssen Pharmaceutica N.V., Belgium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study of the Treatment of Multiple Myeloma in Routine Clinical Practice
- Lead sponsor
- Janssen Pharmaceutica N.V., Belgium
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- November 30, 2014
- Enrollment
- 2,396 (actual)
- Sites
- 159
Conditions
As the registry lists them; a condition with its own page is linked.